NTMT1
Basic information
Region (hg38): 9:129608884-129636135
Previous symbols: [ "C9orf32", "METTL11A" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NTMT1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 14 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 14 | 0 | 0 |
Variants in NTMT1
This is a list of pathogenic ClinVar variants found in the NTMT1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-129613552-G-A | not specified | Likely benign (Jul 06, 2021) | ||
9-129619764-T-C | Likely benign (Feb 01, 2023) | |||
9-129620195-G-A | not specified | Uncertain significance (Sep 09, 2021) | ||
9-129620377-G-A | Likely benign (Feb 01, 2023) | |||
9-129632763-G-T | not specified | Uncertain significance (Sep 04, 2024) | ||
9-129632772-C-G | not specified | Uncertain significance (Apr 07, 2022) | ||
9-129632788-G-A | not specified | Uncertain significance (Dec 31, 2024) | ||
9-129632797-G-T | not specified | Uncertain significance (Sep 04, 2024) | ||
9-129632839-C-T | not specified | Uncertain significance (Nov 09, 2022) | ||
9-129632840-G-A | not specified | Uncertain significance (Nov 26, 2024) | ||
9-129634096-G-C | not specified | Uncertain significance (Feb 25, 2025) | ||
9-129634123-C-T | not specified | Uncertain significance (Jan 22, 2024) | ||
9-129634196-C-T | not specified | Uncertain significance (Oct 25, 2022) | ||
9-129635357-G-A | not specified | Uncertain significance (Oct 02, 2023) | ||
9-129635367-G-A | not specified | Uncertain significance (Oct 18, 2021) | ||
9-129635373-T-A | not specified | Uncertain significance (Nov 21, 2024) | ||
9-129635378-A-G | not specified | Uncertain significance (Nov 15, 2024) | ||
9-129635397-T-G | not specified | Uncertain significance (Dec 28, 2023) | ||
9-129635439-A-G | not specified | Uncertain significance (Oct 06, 2022) | ||
9-129635445-A-G | not specified | Uncertain significance (Dec 12, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NTMT1 | protein_coding | protein_coding | ENST00000372486 | 3 | 27047 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0508 | 0.868 | 125735 | 0 | 12 | 125747 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.29 | 104 | 148 | 0.702 | 0.00000954 | 1479 |
Missense in Polyphen | 38 | 64.986 | 0.58474 | 650 | ||
Synonymous | -0.670 | 75 | 68.0 | 1.10 | 0.00000525 | 435 |
Loss of Function | 1.45 | 3 | 7.19 | 0.417 | 3.04e-7 | 85 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000904 | 0.0000904 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000533 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Distributive alpha-N-methyltransferase that methylates the N-terminus of target proteins containing the N-terminal motif [Ala/Gly/Pro/Ser]-Pro-Lys when the initiator Met is cleaved. Specifically catalyzes mono-, di- or tri-methylation of the exposed alpha-amino group of the Ala, Gly or Ser residue in the [Ala/Gly/Ser]-Pro-Lys motif and mono- or di-methylation of Pro in the Pro-Pro-Lys motif. Some of the substrates may be primed by METTL11B-mediated monomethylation (PubMed:24090352). Catalyzes the trimethylation of the N-terminal Gly in CENPA (after removal of Met-1). Responsible for the N-terminal methylation of KLHL31, MYL2, MYL3, RB1, RCC1, RPL23A and SET. Required during mitosis for normal bipolar spindle formation and chromosome segregation via its action on RCC1. {ECO:0000269|PubMed:20481588, ECO:0000269|PubMed:20668449, ECO:0000269|PubMed:24090352, ECO:0000269|PubMed:26543159}.;
Recessive Scores
- pRec
- 0.124
Intolerance Scores
- loftool
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.09
Haploinsufficiency Scores
- pHI
- 0.171
- hipred
- Y
- hipred_score
- 0.601
- ghis
- 0.615
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ntmt1
- Phenotype
- skeleton phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- spindle organization;chromosome segregation;histone methylation;N-terminal peptidyl-alanine trimethylation;N-terminal peptidyl-glycine methylation;N-terminal peptidyl-proline dimethylation;N-terminal peptidyl-serine dimethylation;N-terminal peptidyl-serine trimethylation
- Cellular component
- nucleus;nucleoplasm;cytoplasm;cytosol
- Molecular function
- protein binding;protein methyltransferase activity;histone methyltransferase activity;N-terminal protein N-methyltransferase activity